UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111 In-ABY-025 Affibody Molecule

Journal of Nuclear Medicine, 2014-05, Vol.55 (5), p.730-735

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

The Journal of nuclear medicine (1978), 2021-04, Vol.62 (4), p.493-499

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

The Journal of nuclear medicine (1978), 2013-10, Vol.54 (10), p.1755

2013

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

The Journal of nuclear medicine (1978), 2016-06, Vol.57 (6), p.867

2016

Link zum Volltext

Verfügbarkeit prüfen

Individualized dosimetry in patients undergoing therapy with Lu-177-DOTA-D-Phe(1)-Tyr(3)-octreotate

European journal of nuclear medicine and molecular imaging, 2010-02, Vol.37 (2), p.212

2010

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

Bioconjugate chemistry, 2013-07, Vol.24 (7), p.1144-1153

2013

Link zum Volltext

Verfügbarkeit prüfen

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

Cancer research (Chicago, Ill.), 2015-10, Vol.75 (20), p.4364-4371

2015

Link zum Volltext

Verfügbarkeit prüfen

177 Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Neuroendocrinology, 2020-07, Vol.110 (7-8), p.662

2020

Link zum Volltext

Verfügbarkeit prüfen

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

European journal of nuclear medicine and molecular imaging, 2016-07, Vol.43 (8), p.1425-1431

2016

Link zum Volltext

Verfügbarkeit prüfen

HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Bioconjugate chemistry, 2010-11, Vol.21 (11), p.2013-2022

2010

Link zum Volltext

Verfügbarkeit prüfen

Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse

Journal of applied physiology (1985), 2012-01, Vol.112 (1), p.225-236

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

PloS one, 2013-12, Vol.8 (12), p.e81932

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

European journal of nuclear medicine and molecular imaging, 2011-03, Vol.38 (3), p.531-539

2011

Link zum Volltext

Verfügbarkeit prüfen

Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls

Physica medica, 2024-01, Vol.117, p.103192-103192, Article 103192

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting of HER2 -Expressing Tumors Using 111 In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Journal of Nuclear Medicine, 2010-07, Vol.51 (7), p.1131-1138

2010

Link zum Volltext

Verfügbarkeit prüfen

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

European journal of nuclear medicine and molecular imaging, 2010, Vol.37 (3), p.613

2010

Link zum Volltext

Verfügbarkeit prüfen

Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden

Physica medica, 2023-12, Vol.116, p.103170-103170, Article 103170

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative evaluation of [sup.111]In-labeled NOTA-conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Oncology reports, 2015-08, p.1042

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Bioconjugate chemistry, 2011-05, Vol.22 (5), p.894-902

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Tc-99m-Z(IGF1R:4551)-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

Amino acids, 2015-02, Vol.47 (2), p.303

2015

Link zum Volltext

Verfügbarkeit prüfen

Re-188-Z(HER2:V2), a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment

The Journal of nuclear medicine (1978), 2014-11, Vol.55 (11), p.1842

2014

Link zum Volltext

Verfügbarkeit prüfen

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

Journal of Nuclear Medicine, 2009-02, Vol.50 (2), p.274-283

2009

Link zum Volltext

Verfügbarkeit prüfen

Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Scientific reports, 2019, Vol.9

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules

Bioconjugate chemistry, 2008-01, Vol.19 (1), p.235-243

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with In-111 using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts

European journal of nuclear medicine and molecular imaging, 2012-03, Vol.39 (3), p.481

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(229)

Publikationsform

Artikel
(230)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(57)
Humans
(56)
Medicine
(40)
Tumors
(40)
Animals
(37)
Female
(37)
Mice
(33)
Nuclear Medicine
(31)
Radiology, Nuclear Medicine & Medical Imaging
(27)
Medicin Och Hälsovetenskap
(26)
Cell Line, Tumor
(25)
Imaging
(25)
Dosimetry
(24)
Radiology
(24)
Medicin
(23)
Male
(22)
Oncology
(21)
Medicine & Public Health
(19)
Radionuclide Imaging
(19)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111 In-ABY-025 Affibody Molecule

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

Individualized dosimetry in patients undergoing therapy with Lu-177-DOTA-D-Phe(1)-Tyr(3)-octreotate

Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

177 Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse

In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls

Targeting of HER2 -Expressing Tumors Using 111 In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden

Comparative evaluation of [sup.111]In-labeled NOTA-conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Evaluation of Tc-99m-Z(IGF1R:4551)-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

Re-188-Z(HER2:V2), a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with In-111 using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts

Suchergebnisse filtern